Phase II clinical trial - Appareil pulmonaire

TROPION-Lung05 (DS1062-A-U202)
Appareil pulmonaire
Ouvert depuis le: 12.08.2021
Site: Paris
Public cible
Adulte
Phase 2, Single-arm, Open-label Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations and Progressed on or After Kinase Inhibitor Therapy and Platinum Based Chemotherapy (TROPION-Lung05)
Description de l'essai

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung cancer (NSCLC) with known actionable genomic alterations.